RU2008114840A - COMPOSITIONS CONTAINING AT LEAST ONE DERIVATIVE NAPHTOIC ACID AND AT LEAST ONE CONNECTION OF TYPE OF POLYURETHANE POLYMER OR ITS DERIVATIVE, WAYS OF THEIR PRODUCTION AND THEIR APPLICATION - Google Patents
COMPOSITIONS CONTAINING AT LEAST ONE DERIVATIVE NAPHTOIC ACID AND AT LEAST ONE CONNECTION OF TYPE OF POLYURETHANE POLYMER OR ITS DERIVATIVE, WAYS OF THEIR PRODUCTION AND THEIR APPLICATION Download PDFInfo
- Publication number
- RU2008114840A RU2008114840A RU2008114840/15A RU2008114840A RU2008114840A RU 2008114840 A RU2008114840 A RU 2008114840A RU 2008114840/15 A RU2008114840/15 A RU 2008114840/15A RU 2008114840 A RU2008114840 A RU 2008114840A RU 2008114840 A RU2008114840 A RU 2008114840A
- Authority
- RU
- Russia
- Prior art keywords
- naphthoic acid
- composition according
- composition
- derivative
- acid derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Polyurethanes Or Polyureas (AREA)
Abstract
1. Композиция, содержащая в физиологически приемлемой среде по меньшей мере одно производное нафтоевой кислоты и по меньшей мере одно соединение типа полиуретанового полимера или его производное, причем указанное производное нафтоевой кислоты находится в диспергированной форме в указанной композиции, причем указанная композиция не содержит какого-либо экстракта ягод пальмы сереноа. ! 2. Композиция по п.1, отличающаяся тем, что производным нафтоевой кислоты является соединение формулы (I): ! ! в которой R представляет собой атом водорода, гидроксильный радикал, разветвленный или неразветвленный алкильный радикал, содержащий от 1 до 4 атомов углерода, алкокси радикал, содержащий от 1 до 10 атомов углерода или циклоалифатический радикал. ! 3. Композиция по п.2, отличающаяся тем, что концентрация производного нафтоевой кислоты составляет от 0,001 до 10%, предпочтительно от 0,01 до 5% и более предпочтительно от 0,05 до 2% по массе относительно общей массы композиции. ! 4. Композиция по п.2, отличающаяся тем, что производное нафтоевой кислоты выбирают из 6-[3-(1-адамантил)-4-метоксифенил]-2-нафтоевой кислоты, 6-[3-(1-адамантил)-4-гидроксифенил]-2-нафтоевой кислоты, 6-[3-(1-адамантил)-4-децилоксифенил]-2-нафтоевой кислоты и 6-[3-(1-адамантил)-4-гексилоксифенил]-2-нафтоевой кислоты. ! 5. Композиция по п.4, отличающаяся тем, что производным нафтоевой кислоты является 6-[3-(1-адамантил)-4-метоксифенил]-2-нафтоевая кислота. ! 6. Композиция по п.5, отличающаяся тем, что концентрация 6-[3-(1-адамантил)-4-метоксифенил]-2-нафтоевой кислоты составляет около 0,1% по массе относительно общей массы композиции. ! 7. Композиция по п.5, отличающаяся тем, что концентрация 6-[3-(1-адамантил)-4-ме�1. A composition comprising in a physiologically acceptable medium at least one naphthoic acid derivative and at least one polyurethane polymer type compound or derivative thereof, said naphthoic acid derivative being in dispersed form in said composition, said composition not containing any extract of berries of palm tree serenoa. ! 2. The composition according to claim 1, characterized in that the derivative of naphthoic acid is a compound of formula (I):! ! in which R represents a hydrogen atom, a hydroxyl radical, a branched or unbranched alkyl radical containing from 1 to 4 carbon atoms, an alkoxy radical containing from 1 to 10 carbon atoms or a cycloaliphatic radical. ! 3. The composition according to claim 2, characterized in that the concentration of the naphthoic acid derivative is from 0.001 to 10%, preferably from 0.01 to 5%, and more preferably from 0.05 to 2% by weight relative to the total weight of the composition. ! 4. The composition according to claim 2, characterized in that the naphthoic acid derivative is selected from 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid, 6- [3- (1-adamantyl) -4 -hydroxyphenyl] -2-naphthoic acid, 6- [3- (1-adamantyl) -4-decyloxyphenyl] -2-naphthoic acid and 6- [3- (1-adamantyl) -4-hexyloxyphenyl] -2-naphthoic acid . ! 5. The composition according to claim 4, characterized in that the derivative of naphthoic acid is 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid. ! 6. The composition according to claim 5, characterized in that the concentration of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid is about 0.1% by weight relative to the total weight of the composition. ! 7. The composition according to claim 5, characterized in that the concentration of 6- [3- (1-adamantyl) -4-me
Claims (27)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0509493 | 2005-09-16 | ||
FR0509493A FR2890861B1 (en) | 2005-09-16 | 2005-09-16 | COMPOSITIONS COMPRISING AT LEAST ONE NAPHTHOTIC ACID DERIVATIVE AND AT LEAST ONE POLYURETHANE POLYMER TYPE COMPOUND OR DERIVATIVES THEREOF, PROCESS FOR PREPARING THE SAME, AND USE THEREOF |
US72527905P | 2005-10-12 | 2005-10-12 | |
US60/725,279 | 2005-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2008114840A true RU2008114840A (en) | 2009-10-27 |
RU2421216C2 RU2421216C2 (en) | 2011-06-20 |
Family
ID=37865321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008114840/15A RU2421216C2 (en) | 2005-09-16 | 2006-09-15 | Compositions containing at least one naphthoic acid derivative and at least one compound of polyurethane polymer or its derivative, methods of producing and applying thereof |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1933827A2 (en) |
JP (2) | JP5074401B2 (en) |
AU (1) | AU2006290364B2 (en) |
CA (1) | CA2622468A1 (en) |
MX (1) | MX2008003422A (en) |
RU (1) | RU2421216C2 (en) |
WO (1) | WO2007031883A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7820186B2 (en) | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
FR2916966B1 (en) * | 2007-06-11 | 2011-01-14 | Galderma Res & Dev | COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE, AND USES THEREOF |
FR2916975B1 (en) * | 2007-06-11 | 2009-09-04 | Galderma Res & Dev | COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND, ANTI-IRRITANT COMPOUND AND BENZOYL PEROXIDE, AND USES THEREOF |
WO2009007341A2 (en) | 2007-07-06 | 2009-01-15 | Galderma Research & Development | Compositions for topical application for the treatment of keratinization disorders |
EP2065032A1 (en) | 2007-11-27 | 2009-06-03 | Galderma Research & Development | A method for producing adapalene gels |
KR101538187B1 (en) * | 2007-11-30 | 2015-07-22 | 갈데르마 리써어치 앤드 디벨로프먼트 | Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent |
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
AU2009348470B2 (en) | 2009-06-24 | 2015-04-02 | Strategic Science & Technologies, Llc | Topical composition containing ibuprofen |
JP5521190B2 (en) * | 2009-10-01 | 2014-06-11 | 国立大学法人東京工業大学 | Collagen composition and method for producing the same |
US20130203850A1 (en) * | 2010-04-29 | 2013-08-08 | Galderma Research & Development | Method for treating scars with adapalene 0.3% |
JP2014504592A (en) | 2010-12-29 | 2014-02-24 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | Treatment of erectile dysfunction and other indications |
ES2700148T3 (en) * | 2012-03-09 | 2019-02-14 | Covestro Deutschland Ag | Aqueous polyurethane dispersion for the treatment of acne |
WO2019240290A1 (en) * | 2018-06-16 | 2019-12-19 | ロート製薬株式会社 | Topical composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2065912T3 (en) * | 1987-07-16 | 1995-03-01 | Univ California | COMPOSITIONS TO IMPROVE THE SKIN PENETRATION OF PHARMACOLOGICALLY ACTIVE AGENTS. |
JPH061851A (en) * | 1992-06-19 | 1994-01-11 | Toyo Ink Mfg Co Ltd | Pigment composition and aqueous pigment dispersion |
US6358541B1 (en) * | 2000-05-03 | 2002-03-19 | David S. Goodman | Topical preparation for the treatment of hair loss |
DK1532974T3 (en) * | 2002-03-12 | 2009-05-11 | Galderma Res & Dev | Composition comprising 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthic acid, for the treatment of dermatological disorders |
-
2006
- 2006-09-15 AU AU2006290364A patent/AU2006290364B2/en active Active
- 2006-09-15 EP EP06831837A patent/EP1933827A2/en not_active Withdrawn
- 2006-09-15 JP JP2008530661A patent/JP5074401B2/en active Active
- 2006-09-15 WO PCT/IB2006/003852 patent/WO2007031883A2/en active Application Filing
- 2006-09-15 MX MX2008003422A patent/MX2008003422A/en active IP Right Grant
- 2006-09-15 RU RU2008114840/15A patent/RU2421216C2/en active
- 2006-09-15 CA CA002622468A patent/CA2622468A1/en not_active Abandoned
-
2012
- 2012-06-20 JP JP2012138489A patent/JP2012184258A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2006290364B2 (en) | 2012-07-05 |
WO2007031883A2 (en) | 2007-03-22 |
MX2008003422A (en) | 2008-03-27 |
WO2007031883A3 (en) | 2007-09-13 |
JP5074401B2 (en) | 2012-11-14 |
JP2009508843A (en) | 2009-03-05 |
AU2006290364A1 (en) | 2007-03-22 |
JP2012184258A (en) | 2012-09-27 |
RU2421216C2 (en) | 2011-06-20 |
EP1933827A2 (en) | 2008-06-25 |
CA2622468A1 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2008114840A (en) | COMPOSITIONS CONTAINING AT LEAST ONE DERIVATIVE NAPHTOIC ACID AND AT LEAST ONE CONNECTION OF TYPE OF POLYURETHANE POLYMER OR ITS DERIVATIVE, WAYS OF THEIR PRODUCTION AND THEIR APPLICATION | |
JP6884522B2 (en) | Topical delivery of skin compositions with low pH | |
RU2009124488A (en) | COMPOSITIONS CONTAINING BENZOIL PEROXIDE, AT LEAST ONE DERIVATIVE OF NAPHTOIC ACID AND AT LEAST ONE CONNECTION OF TYPE OF POLYURETHANE POLYMERS OR THEIR DERIVATIVES, AND THEIR | |
RU2014126090A (en) | COMPOSITIONS INCLUDING AT LEAST ONE DERIVATIVE OF NAPHTOIC ACID, BENZOYL PEROXIDE AND AT LEAST ONE FILM-FORMING COMPONENT, WAYS OF THEIR PRODUCTION AND THEIR APPLICATION | |
JP5254645B2 (en) | Vesicle composition and external preparation for skin containing the vesicle composition | |
KR20110058949A (en) | Cosmetic composition stabilized higher oily part | |
JPH09202708A (en) | Stable gelling composition containing electrolyte | |
WO2005051334A1 (en) | Oil-in-water-type emulsified cosmetic preparation and process for producing the same | |
JP6057461B2 (en) | Alpha gel structure and cosmetic or skin external preparation containing the same | |
TW200413020A (en) | Vesicle dispersion and cosmetic containing the same | |
JP3894064B2 (en) | Oil-based thickening gel composition, emulsified composition using the composition, and preparation method thereof | |
GB2064363A (en) | Volatile Silicone-water Emulsion and Methods of Preparation and Use | |
JP2023513098A (en) | Retinol-based inclusions, methods of making and using the same | |
JP5043467B2 (en) | Topical skin preparation | |
BRPI0617045B1 (en) | composition, process for preparing a composition, use of a composition and cosmetic use of a composition | |
JP2009263346A (en) | Emulsion-type cosmetic containing kinetin | |
JPH08283303A (en) | Emulsifier comprising higher fatty acid dextrin, emulsion composition containing the same, and cosmetic | |
JPS58183938A (en) | Emulsified composition | |
JPS63301826A (en) | Drug for external use | |
CN115381723A (en) | Polyol-in-oil-in-water multiple liquid crystal emulsion and preparation method and application thereof | |
JP2010270067A (en) | Emulsion composition | |
JPH0435211B2 (en) | ||
JP2007106694A (en) | Skin care agent for external use | |
JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
JPH045490B2 (en) |